Advantage Ibs

Troublesome ailment is elusive but treatable
Bangkok Post
By following a proper course of treatment, IBS symptoms such as cramps, diarrhoea, constipation amd bloating will be considerably alleviated and should eventually disappear, while the potential danger posed by a leaky gut will be removed. ...
Research and Markets: the global Irritable Bowel Syndrome (IBS) Therapeutics ...SunHerald.com

all 11 news articles »

MicroDose Therapeutx Begins Phase 1 Trial of MDT-637 for Treatment of ... - MarketWatch (press release)

MicroDose Therapeutx Begins Phase 1 Trial of MDT-637 for Treatment of ...
MarketWatch (press release)
The company develops its products and technologies independently, as well as in partnership with leading pharmaceutical companies. MicroDose's current pipeline targets respiratory diseases such as asthma, COPD and RSV, as well as IBS-C and ...

and more »

Honey's healing power: Golden nectar can be more than just a taste treat - Royal Oak Daily Tribune

Honey's healing power: Golden nectar can be more than just a taste treat
Royal Oak Daily Tribune
“The chemicals go into the honey we consume and it's not good for us at all,” said Poupore, adding that raw, wild honey has been shown to cure everything from “IBS to ulcers, diarrhea, skin wounds, staff infections and even cancer.” Continued. ...

Almirall files IBS-C drug, signs pact with Nycomed for Kestine - Pharma Times

Mass High Tech

Almirall files IBS-C drug, signs pact with Nycomed for Kestine
Pharma Times
First up, the Spanish drugmaker has submitted a marketing authorisation application to the European Medicines Agency for Constella (linaclotide), an investigational guanylate cyclase-C receptor agonist for the treatment of irritable bowel syndrome with ...
Almirall Announces Regulatory Filing of linaclotide for the Treatment of ...PR Newswire (press release)
Ironwood Announces Linaclotide European Regulatory Submission for the ...MarketWatch (press release)
Ironwood submits bowel drug to European regulatory groupMass High Tech
Benzinga -Pharmaceutical Business Review -Zenopa
all 45 news articles »

Ulcerative colitis, IBS and Crohn's disease segments of gastrointestinal ... - MarketWatch (press release)

Ulcerative colitis, IBS and Crohn's disease segments of gastrointestinal ...
MarketWatch (press release)
A rapidly growing area within the gastrointestinal disorder market is irritable bowel syndrome, which affects between 12-20% of the global population. The condition has a substantial pipeline of new treatments, eg, Linaclotide (linaclotide acetate) and ...

and more »

Add RSS Feeds To My Web Pages
Increase Web Traffic

Additional Advantage Ibs Resources:

1. Amazon.com: Digestive Advantage IBS, Irritable Bowel Syndrome
Amazon.com: Digestive Advantage IBS, Irritable Bowel Syndrome, Caplets, 92-Count Bottle: Health & Personal Care.

2. Amazon.com: Digestive Advantage IBS 32 Chewable Tablets: Health
Amazon.com: Digestive Advantage IBS 32 Chewable Tablets: Health & Personal Care.

3. FAQ - Digestive Advantage IBS
Digestive Advantage IBS is a unique, once per day treatment for the symptoms associated with What is the active ingredient in Digestive Advantage IBS?

Want your site featured on this page?

Want your site featured on this targeted page?

Do you have an ezine?
List your ezine in our Free Newsletter Directory!